» Articles » PMID: 29172937

Panretinal Photocoagulation: A Review of Complications

Overview
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2017 Nov 28
PMID 29172937
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Panretinal photocoagulation (PRP) is a mainstay of therapy for retinal ischemic disease. The procedure involves creating thermal burns in the peripheral retina leading to tissue coagulation, the overall consequence of which is improved retinal oxygenation. While highly effective, there have been concerns historically regarding the anatomic effects and visual complications following PRP, the most common of which include choroidal effusions, exudative retinal detachments, macular edema, visual field deficits, and night vision defects. The occurrence of these complications is closely tied to laser parameters such as increased duration and power and intensive treatment in a single sitting, all of which cause increased dispersion of thermal energy within the retina and choroid. The advent of newer laser delivery systems, such as the multispot pattern laser, has greatly mitigated but not eliminated these issues. The following article reviews the most common complications following PRP treatment, including reported occurrences, inciting factors, and underlying pathophysiology.

Citing Articles

Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies.

Seo H, Park S, Song M Cells. 2025; 14(5).

PMID: 40072104 PMC: 11898816. DOI: 10.3390/cells14050376.


The influence of UV-visible light, microwave radiation, argon laser, and heating and aging processes on silicone oil utilized as intravitreal implants: Experimental exposure with clinical correlation.

Al-Dwairi R, Ahmad A, Aleshawi A, Al-Bataineh Q, Bani-Salameh A, Aljarrah I PLoS One. 2024; 19(12):e0316212.

PMID: 39739730 PMC: 11687662. DOI: 10.1371/journal.pone.0316212.


Revamping anti-cGAS-STING therapy via an injectable thermo-responsive supramolecular hydrogel for pathological retinal angiogenesis.

Yan D, Wang Y, Ouyang W, Huang C, Chen Q, Hu J Asian J Pharm Sci. 2024; 19(5):100969.

PMID: 39474128 PMC: 11513468. DOI: 10.1016/j.ajps.2024.100969.


Laser Treatment for Diabetic Retinopathy: History, Mechanism, and Novel Technologies.

Wang S, Hua R, Zhao Y, Liu L J Clin Med. 2024; 13(18).

PMID: 39336925 PMC: 11432231. DOI: 10.3390/jcm13185439.


Targeting pericyte retention in Diabetic Retinopathy: a review.

Bohler F, Bohler L, Taranikanti V Ann Med. 2024; 56(1):2398200.

PMID: 39268600 PMC: 11404372. DOI: 10.1080/07853890.2024.2398200.